Home
About
Overview
Sharing Data
ORCID
Help
History (3)
CHARACTERIZATION OF ENHANCER IN RIBOSOMAL DNA
Editorial: Exploring the Potential of Particle Radiotherapy: Helium, Neutrons, Carbon, and Other Heavy Ions.
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Editorial: Exploring the Potential of Particle Radiotherapy: Helium, Neutrons, Carbon, and Other Heavy Ions.
Editorial: Exploring the Potential of Particle Radiotherapy: Helium, Neutrons, Carbon, and Other Heavy Ions. Front Oncol. 2021; 11:740974.
View in:
PubMed
authors with profiles
Timothy Dean Malouff